My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 598

    1.

    Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

    Diabetes. 1997 Jul;46(7):1182-8.PMID: 9200654 [PubMed - indexed for MEDLINE]Related articles

    2.

    Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH.

    Diabetes. 1994 Sep;43(9):1108-13.PMID: 8070610 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.

    Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH.

    Scand J Clin Lab Invest. 1997 Aug;57(5):427-34.PMID: 9279969 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.

    Diabetes Care. 2000 Dec;23(12):1725-30.PMID: 11128341 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.

    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.

    Diabetes. 1997 Mar;46(3):481-7.PMID: 9032106 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.

    Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH.

    Diabetes Care. 1999 Mar;22(3):491-4.PMID: 10097934 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.

    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.

    Afr J Med Med Sci. 2002 Mar;31(1):53-7.PMID: 12518931 [PubMed - indexed for MEDLINE]Related articles

    8.

    Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.

    Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S.

    Kidney Int. 1996 Nov;50(5):1641-50.PMID: 8914031 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

    Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

    Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.

    Lacourcière Y, Bélanger A, Godin C, Hallé JP, Ross S, Wright N, Marion J.

    Kidney Int. 2000 Aug;58(2):762-9.PMID: 10916100 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.

    Suwelack B, Kobelt V, Erfmann M, Hausberg M, Gerhardt U, Rahn KH, Hohage H.

    Transpl Int. 2003 May;16(5):313-20. Epub 2003 Feb 20.PMID: 12759722 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.

    Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, Swaminathan R, Nicholls MG, Critchley JA, Cockram CS.

    Kidney Int. 2000 Feb;57(2):590-600.PMID: 10652036 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.

    Rossing K, Jacobsen P, Pietraszek L, Parving HH.

    Diabetes Care. 2003 Aug;26(8):2268-74.PMID: 12882847 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.

    Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R.

    Diabetes. 1996 Feb;45(2):216-22.PMID: 8549868 [PubMed - indexed for MEDLINE]Related articles

    15.

    A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.

    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.

    Clin Nephrol. 2001 May;55(5):375-83.PMID: 11393383 [PubMed - indexed for MEDLINE]Related articles

    16.

    Renal and metabolic effects of 1-year treatment with ramipril or atenolol in NIDDM patients with microalbuminuria.

    Schnack C, Hoffmann W, Hopmeier P, Schernthaner G.

    Diabetologia. 1996 Dec;39(12):1611-6.PMID: 8960851 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.

    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C; Melbourne Diabetic Nephropathy Study Group.

    Diabet Med. 2004 Nov;21(11):1192-9.PMID: 15498085 [PubMed - indexed for MEDLINE]Related articles

    18.

    Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.

    Leoncini G, Martinoli C, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Derchi LE, Deferrari G, Pontremoli R.

    Nephron. 2002 Feb;90(2):169-73.PMID: 11818701 [PubMed - indexed for MEDLINE]Related articles

    19.

    Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.

    Brocco E, Velussi M, Cernigoi AM, Abaterusso C, Bruseghin M, Carraro A, Sambataro M, Piarulli F, Sfriso A, Nosadini R.

    J Nephrol. 2001 Nov-Dec;14(6):461-71.PMID: 11783602 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.

    Diabetes Care. 1998 Jan;21(1):104-10.PMID: 9538979 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity